Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Hold Rating by StockNews.com
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Monday. Several other equities research analysts have also commented on the stock. Piper Sandler lifted their price target on shares of Teva Pharmaceutical Industries from $23.00 […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Monday. Several other equities research analysts have also commented on the stock. Piper Sandler lifted their price target on shares of Teva Pharmaceutical Industries from $23.00 […]